S. A. Francis, S. Yardley, B. Franklin, M. Ogden, A. Kajamaa, K. Mattick
{"title":"A model of intended and ideal prescribing and medication use in symptom control in palliative care: an international scoping review","authors":"S. A. Francis, S. Yardley, B. Franklin, M. Ogden, A. Kajamaa, K. Mattick","doi":"10.1093/ijpp/riad074.024","DOIUrl":null,"url":null,"abstract":"UK health policy documents are committed to improving personalised palliative care for people of all ages, prioritising access to coordinated care and health inequity. The UK Health and Care Act 2022 has stated it is a statutory requirement for Integrated Care Boards to commission palliative and end of life care services. Palliative care focuses on improving the quality of life of patients and families who are facing problems associated with life-limiting illness, and often involves medication for symptom control. Medication has been reported in 19% of NHS serious incident reports involving palliative patients, mostly occurring in patient homes, with half when specialists did not provide care.1 To document a model of existing evidence illustrating intended processes when palliative medications are prescribed for symptom control and used by adults at home, in hospital and hospice settings. We performed a scoping review using JBI methodology.2 Population (P): (i) adults in the last phase of life, (ii) informal carers supporting an adult as described above, (iii) healthcare professionals providing palliative care for symptom control. Concept (C): multistep processes for medication use for symptom control in palliative care. Context (C): care settings where palliative care may be anticipated, planned or happen. A systematic search were undertaken in Medline, CINAHL, Embase, plus Google scholar and Google images. There were no date limits; searches were confined to English language. Published and unpublished literature meeting the PCC framework were included. Screening and extraction of data were performed by two independent reviewers (SAF and SY). Studies were categorised inductively and results collated descriptively. Ethical approval was obtained from the NHS HRA and HCRW (ref: 21/LO/0459). 19,753 titles and abstracts were screened; 929 underwent full text review; 308 peer-reviewed articles and grey literature documents were retained to build the intended model. The majority of these papers (212; 69%) provided simple process steps involving expertise/judgement, supply chain/access, administration, prescribing/deprescribing, rationalisation, repurposing. The remaining 96 papers warranted richer thematic analysis. Most studies took place in the UK, Australia or USA in home/community settings. Analysis illuminated detail about ‘hidden work’ (participants’ actions in medication management), ‘hot spots’ (problematic areas e.g. out-of-hours care and the reliance on carers) and ‘cold spots’ (areas with less attention such as whose responsibility for keeping carers informed of changes and what is adequate support for safe medicines use at home). There is a growing interest in how best to work together across boundaries to enable getting the right medication to the right person at the right time and place. This scoping review documents the existing evidence of intended processes and a model of ideal prescribing and medication use in symptom control in palliative care. This study is limited to adult palliative care services only. A strength of the study is the use of JBI methodology. Using ethnographic methods and the conceptual tools of Activity Theory, we will refine this intended model with a study of what happens in practice3 to build a theoretically-informed, empirically-evidenced model of medication management across palliative care contexts. 1. Yardley I, Yardley S, Williams H, Carson-Stevens A, Donaldson L. Patient safety in palliative care: A mixed-methods study of reports to a national database of serious incidents. Pall Med 2018;32:1353-1362. 2. The Joanna Briggs Institute. Joanna Briggs Institute Reviewers’ Manual: 2015 edition / supplement: Methodology for JBI Scoping Reviews. Adelaide, Australia: The Joanna Briggs Institute 2015. http://joannabriggs.org/assets/docs/sumari/Reviewers-Manual_Methodology-for-JBI-Scoping-Reviews_2015_v2.pdf 3. Yardley S, Francis SA, Dean Franklin B, Ogden M, Kajamaa A, Mattick K. Getting palliative medications right across the contexts of homes, hospitals and hospices: protocol to synthesise scoping review and ethnographic methods in an activity theory analysis. BMJ Open 2022 12:e061754.","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" 9","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmacy Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ijpp/riad074.024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
UK health policy documents are committed to improving personalised palliative care for people of all ages, prioritising access to coordinated care and health inequity. The UK Health and Care Act 2022 has stated it is a statutory requirement for Integrated Care Boards to commission palliative and end of life care services. Palliative care focuses on improving the quality of life of patients and families who are facing problems associated with life-limiting illness, and often involves medication for symptom control. Medication has been reported in 19% of NHS serious incident reports involving palliative patients, mostly occurring in patient homes, with half when specialists did not provide care.1 To document a model of existing evidence illustrating intended processes when palliative medications are prescribed for symptom control and used by adults at home, in hospital and hospice settings. We performed a scoping review using JBI methodology.2 Population (P): (i) adults in the last phase of life, (ii) informal carers supporting an adult as described above, (iii) healthcare professionals providing palliative care for symptom control. Concept (C): multistep processes for medication use for symptom control in palliative care. Context (C): care settings where palliative care may be anticipated, planned or happen. A systematic search were undertaken in Medline, CINAHL, Embase, plus Google scholar and Google images. There were no date limits; searches were confined to English language. Published and unpublished literature meeting the PCC framework were included. Screening and extraction of data were performed by two independent reviewers (SAF and SY). Studies were categorised inductively and results collated descriptively. Ethical approval was obtained from the NHS HRA and HCRW (ref: 21/LO/0459). 19,753 titles and abstracts were screened; 929 underwent full text review; 308 peer-reviewed articles and grey literature documents were retained to build the intended model. The majority of these papers (212; 69%) provided simple process steps involving expertise/judgement, supply chain/access, administration, prescribing/deprescribing, rationalisation, repurposing. The remaining 96 papers warranted richer thematic analysis. Most studies took place in the UK, Australia or USA in home/community settings. Analysis illuminated detail about ‘hidden work’ (participants’ actions in medication management), ‘hot spots’ (problematic areas e.g. out-of-hours care and the reliance on carers) and ‘cold spots’ (areas with less attention such as whose responsibility for keeping carers informed of changes and what is adequate support for safe medicines use at home). There is a growing interest in how best to work together across boundaries to enable getting the right medication to the right person at the right time and place. This scoping review documents the existing evidence of intended processes and a model of ideal prescribing and medication use in symptom control in palliative care. This study is limited to adult palliative care services only. A strength of the study is the use of JBI methodology. Using ethnographic methods and the conceptual tools of Activity Theory, we will refine this intended model with a study of what happens in practice3 to build a theoretically-informed, empirically-evidenced model of medication management across palliative care contexts. 1. Yardley I, Yardley S, Williams H, Carson-Stevens A, Donaldson L. Patient safety in palliative care: A mixed-methods study of reports to a national database of serious incidents. Pall Med 2018;32:1353-1362. 2. The Joanna Briggs Institute. Joanna Briggs Institute Reviewers’ Manual: 2015 edition / supplement: Methodology for JBI Scoping Reviews. Adelaide, Australia: The Joanna Briggs Institute 2015. http://joannabriggs.org/assets/docs/sumari/Reviewers-Manual_Methodology-for-JBI-Scoping-Reviews_2015_v2.pdf 3. Yardley S, Francis SA, Dean Franklin B, Ogden M, Kajamaa A, Mattick K. Getting palliative medications right across the contexts of homes, hospitals and hospices: protocol to synthesise scoping review and ethnographic methods in an activity theory analysis. BMJ Open 2022 12:e061754.
英国的卫生政策文件致力于改善所有年龄段人群的个性化姑息关怀,优先考虑协调关怀的获取和健康不平等问题。英国《2022 年健康与护理法案》规定,综合护理委员会必须委托提供姑息关怀和生命末期关怀服务。 姑息关怀的重点是改善面临与局限生命的疾病相关问题的患者和家属的生活质量,通常涉及药物控制症状。 在涉及姑息关怀患者的英国国家医疗服务系统严重事故报告中,19% 的报告涉及药物治疗,其中大部分发生在患者家中,半数是在专科医生未提供护理的情况下发生的1。 2 研究对象(P):(i) 处于生命最后阶段的成年人;(ii) 支持上述成年人的非正式照护者;(iii) 提供姑息关怀以控制症状的医护人员。概念(C):在姑息关怀中使用药物控制症状的多步骤过程。背景(C):可能预期、计划或发生姑息关怀的护理环境。 在 Medline、CINAHL、Embase 以及 Google scholar 和 Google images 中进行了系统搜索。没有日期限制;搜索仅限于英语。符合 PCC 框架的已发表和未发表的文献均被纳入。由两名独立审稿人(SAF 和 SY)负责筛选和提取数据。对研究进行归纳分类,并对结果进行描述性整理。 已获得英国国家医疗服务系统 HRA 和 HCRW 的伦理批准(编号:21/LO/0459)。 筛选了 19,753 篇标题和摘要;929 篇进行了全文审阅;保留了 308 篇同行评审文章和灰色文献,以建立预期模型。其中大部分论文(212 篇;69%)提供了简单的流程步骤,涉及专业知识/判断、供应链/获取、管理、处方/处方外、合理化、再利用。其余 96 篇论文需要进行更丰富的专题分析。大多数研究发生在英国、澳大利亚或美国的家庭/社区环境中。分析揭示了 "隐性工作"(参与者在用药管理方面的行动)、"热点"(存在问题的领域,如非工作时间护理和对护理人员的依赖)和 "冷点"(关注度较低的领域,如谁有责任让护理人员及时了解变化,以及什么是对在家安全用药的充分支持)方面的细节。 人们越来越关注如何以最佳方式开展跨部门合作,以便在正确的时间和地点为正确的人提供正确的药物。本范围界定综述记录了姑息关怀中症状控制的预期流程和理想处方与用药模式的现有证据。本研究仅限于成人姑息关怀服务。本研究的优势之一是采用了联合调查法。我们将利用人种学方法和活动理论的概念工具,通过对实践中发生的情况3 的研究来完善这一预期模式,从而建立一个有理论依据、有经验证明的姑息关怀用药管理模式。 1.Yardley I, Yardley S, Williams H, Carson-Stevens A, Donaldson L. 《姑息关怀中的患者安全》:严重事故国家数据库报告的混合方法研究。Pall Med 2018;32:1353-1362. 2.Joanna Briggs Institute.Joanna Briggs Institute Reviewers' Manual:2015 年版/补充:Joanna Briggs Institute Reviewers' Manual: 2015 edition / supplement: Methodology for JBI Scoping Reviews.澳大利亚阿德莱德:http://joannabriggs.org/assets/docs/sumari/Reviewers-Manual_Methodology-for-JBI-Scoping-Reviews_2015_v2.pdf 3.Yardley S, Francis SA, Dean Franklin B, Ogden M, Kajamaa A, Mattick K. Getting palliative medications right across the contexts of homes, hospitals and hospices: protocol to synthesize scoping review and ethnographic methods in an activity theory analysis.BMJ Open 2022 12:e061754.
期刊介绍:
The International Journal of Pharmacy Practice (IJPP) is a Medline-indexed, peer reviewed, international journal. It is one of the leading journals publishing health services research in the context of pharmacy, pharmaceutical care, medicines and medicines management. Regular sections in the journal include, editorials, literature reviews, original research, personal opinion and short communications. Topics covered include: medicines utilisation, medicine management, medicines distribution, supply and administration, pharmaceutical services, professional and patient/lay perspectives, public health (including, e.g. health promotion, needs assessment, health protection) evidence based practice, pharmacy education. Methods include both evaluative and exploratory work including, randomised controlled trials, surveys, epidemiological approaches, case studies, observational studies, and qualitative methods such as interviews and focus groups. Application of methods drawn from other disciplines e.g. psychology, health economics, morbidity are especially welcome as are developments of new methodologies.